Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04269369
What this trial is testing

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Who this might be right for
Colon CancerStomach TumorAnal Tumor+2 more
Jessa Hospital 250
Not applicableStudy completedNCT03461341
What this trial is testing

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic CancerRecurrent Esophageal Cancer+4 more
St. James's Hospital, Ireland 3,000
Not applicableUnknownNCT04984096
What this trial is testing

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 50
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Testing effectiveness (Phase 2)Ended earlyNCT00177255
What this trial is testing

Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

Who this might be right for
Cancer
University of Pittsburgh 40
Not applicableUnknownNCT04001478
What this trial is testing

Non-invasive Testing for Early oEesophageal Cancer and Dysplasia

Who this might be right for
Oesophageal CancerBarrett EsophagusBarretts Esophagus With Dysplasia
Imperial College London 1,000
Not applicableActive Not RecruitingNCT06302660
What this trial is testing

Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

Who this might be right for
Oesophageal CancerQuality of LifeBacterial Overgrowth
Imperial College London 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06469060
What this trial is testing

Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 34
Not applicableActive Not RecruitingNCT06401447
What this trial is testing

TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 50
Not applicableUnknownNCT04675138
What this trial is testing

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care

Who this might be right for
Gastric CancerEsophageal CancerEsophagogastric Junction Cancer
National University Hospital, Singapore 1,000
Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Not applicableStudy completedNCT04314349
What this trial is testing

Radiogenomics in Aerodigestive Tract Cancers

Who this might be right for
Cancer, LungCancer of EsophagusCancer of Head and Neck
Buddhist Tzu Chi General Hospital 139
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Large-scale testing (Phase 3)UnknownNCT01937208
What this trial is testing

Comparable Study of Different Radiation Dose in Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Zhejiang Cancer Hospital 300
Large-scale testing (Phase 3)Study completedNCT02644408
What this trial is testing

Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy

Who this might be right for
Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology 184
Not applicableStudy completedNCT05600335
What this trial is testing

Short-term Outcomes of ERAS Protocol in RAME for Esophageal Cancer

Who this might be right for
Esophageal Cancer Patients
West China Hospital 211
Testing effectiveness (Phase 2)Active Not RecruitingNCT05480384
What this trial is testing

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Who this might be right for
Esophageal AdenocarcinomaEsophageal CancerHER-2 Protein Overexpression+1 more
Brown University 1
Early research (Phase 1)UnknownNCT03094884
What this trial is testing

Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer

Who this might be right for
Lung CancerEsophageal Cancer
Fox Chase Cancer Center 40
Not applicableNot Yet RecruitingNCT07104838
What this trial is testing

Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer

Who this might be right for
Esophageal Cancer (EsC)
The First Affiliated Hospital of Guangzhou Medical University 500
Large-scale testing (Phase 3)Ended earlyNCT02551458
What this trial is testing

Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Who this might be right for
Epidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more
Centre Hospitalier Universitaire Dijon 188
Next Page